Phase I Trial Of Regulatory T-Cell Donor Lymphocyte Infusion Plus Daily Low-Dose Interleukin-2 For Steroid-Refractory Chronic Graft-Versus-Host Disease

BLOOD(2017)

引用 0|浏览17
暂无评分
关键词
donor,t-cell,low-dose,steroid-refractory,graft-versus-host
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要